home / stock / sigy / sigy short
Short Information | Sigyn Therapeutics Inc (OTCMKTS:SIGY)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 73,575 |
Total Actual Volume | 100,658 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 18 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 3,679 |
Average Short Percentage | 80.06% |
Is there a SIGY Short Squeeze or Breakout about to happen?
See the SIGY Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-13-2024 | $0 | $5.25 | $0 | $0 | 5 | 5 | 100% |
05-15-2024 | $5.25 | $5.25 | $5.25 | $5.25 | 445 | 445 | 100% |
05-07-2024 | $5 | $5 | $5 | $5 | 525 | 500 | 95.24% |
05-03-2024 | $5.25 | $5.25 | $5.25 | $5.25 | 300 | 245 | 81.67% |
05-01-2024 | $5.75 | $5.5 | $5.75 | $5.5 | 400 | 200 | 50% |
04-30-2024 | $6 | $6 | $6 | $6 | 290 | 290 | 100% |
04-29-2024 | $0 | $6.34 | $0 | $0 | 10 | 10 | 100% |
04-26-2024 | $6.25 | $6.34 | $6.34 | $6.25 | 200 | 100 | 50% |
04-19-2024 | $5.75 | $5.75 | $5.75 | $5.75 | 256 | 100 | 39.06% |
04-17-2024 | $0 | $6.1 | $0 | $0 | 25 | 25 | 100% |
04-15-2024 | $6.1 | $6.1 | $6.1 | $6.1 | 100 | 100 | 100% |
04-12-2024 | $6.25 | $6 | $6.25 | $6 | 200 | 200 | 100% |
03-28-2024 | $6 | $5.5 | $6 | $5.5 | 519 | 144 | 27.75% |
03-26-2024 | $4.5 | $4.5 | $4.5 | $4.5 | 513 | 395 | 77% |
03-04-2024 | $5 | $5 | $5 | $5 | 495 | 294 | 59.39% |
01-30-2024 | $0.139 | $0.15 | $0.199 | $0.12 | 46,891 | 28,638 | 61.07% |
01-29-2024 | $0.129 | $0.129 | $0.129 | $0.129 | 1,884 | 1,884 | 100% |
01-16-2024 | $0.1145 | $0.12 | $0.12 | $0.1145 | 5,200 | 4,000 | 76.92% |
01-12-2024 | $0.12 | $0.12 | $0.12 | $0.12 | 4,500 | 4,500 | 100% |
12-18-2023 | $0.101 | $0.11 | $0.11 | $0.09 | 37,900 | 31,500 | 83.11% |
News, Short Squeeze, Breakout and More Instantly...
Sigyn Therapeutics Inc Company Name:
SIGY Stock Symbol:
OTCMKTS Market:
Sigyn Therapeutics Inc Website:
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the company reported a loss from operations of $629,972, as compared to an operating loss of $521,258 for the compar...
SAN DIEGO, CA - ( NewMediaWire ) - May 15, 2024 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the C...
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, today announced that it has published an article entitled: “Sigyn Therapy(TM), an Emerging Candidate to Address Endotoxemia, Sepsis and Drug-Resistant Viral & Bacterial Infections.” “Wh...